T1	tradename 104 109	EMEND
T3	tradename 171 177	EMEND.
T5	tradename 179 184	EMEND
T7	nanoparticle 186 212	fosaprepitant dimeglumine)
T9	routeofadministration 232 243	intravenous
T11	fdaapprovaldate 271 275	2008
T13	tradename 355 360	EMEND
T15	indication 546 552	nausea
T17	indication 557 565	vomiting
T19	indication 613 656	highly emetogenic cancer chemotherapy (HEC)
T21	indication 688 721	prevention of nausea and vomiting
T23	indication 768 815	moderately emetogenic cancer chemotherapy (MEC)
T25	indication 968 971	HEC
T27	tradename 995 1000	EMEND
T29	dose 1016 1023	150 mg)
T31	tradename 1161 1166	EMEND
T33	tradename 1202 1207	EMEND
T35	indication 1246 1273	prevent nausea and vomiting
T37	indication 1285 1288	HEC
T39	indication 1351 1354	HEC
T41	indication 1359 1362	MEC
T43	tradename 1387 1392	EMEND
T45	dose 1408 1415	115 mg)
T47	tradename 1531 1536	EMEND
T49	dose 1547 1553	80 mg)
T51	routeofadministration 1564 1570	orally
T53	tradename 1589 1594	EMEND
T55	tradename 1613 1618	EMEND
T57	indication 1653 1680	prevent nausea and vomiting
T59	indication 1692 1695	HEC
T61	indication 1699 1702	MEC
T63	routeofadministration 1911 1922	intravenous
T65	dose 1967 1973	150 mg
T67	dose 1978 1984	115 mg
T69	activeingredient 2211 2221	aprepitant
T71	activeingredient 2420 2433	Fosaprepitant
T73	activeingredient 2757 2770	fosaprepitant
T75	activeingredient 2774 2784	aprepitant
T77	activeingredient 3026 3039	fosaprepitant
T79	activeingredient 3043 3053	aprepitant
T81	routeofadministration 3252 3256	oral
T83	activeingredient 3257 3267	aprepitant
T85	adversereaction 3395 3402	hiccups
T87	adversereaction 3404 3420	asthenia/fatigue
T89	adversereaction 3422 3439	AST/ALT increased
T91	adversereaction 3441 3449	headache
T93	adversereaction 3451 3463	constipation
T95	adversereaction 3465 3473	anorexia
T97	adversereaction 3475 3484	dyspepsia
T99	adversereaction 3486 3494	diarrhea
T101	adversereaction 3496 3507	eructation.
T103	tradename 3546 3551	EMEND
T105	indication 3611 3614	HEC
T107	routeofadministration 3628 3632	oral
T109	activeingredient 3633 3644	aprepitant.
T111	adversereaction 3658 3681	infusion site reactions
T113	tradename 3701 3706	EMEND
T115	company 3776 3805	Merck Sharp &amp; Dohme Corp.
T117	company 3823 3838	Merck &amp; Co.
T119	company 3840 3844	Inc.
T121	activeingredient 4016 4029	fosaprepitant
T123	activeingredient 4033 4043	aprepitant
T125	activeingredient 4154 4164	aprepitant
T127	tradename 4212 4217	EMEND
T129	indication 4562 4595	Prevention of Nausea and Vomiting
T131	indication 4612 4648	Highly Emetogenic Chemotherapy (HEC)
T133	indication 4654 4687	Prevention of Nausea and Vomiting
T135	indication 4704 4744	Moderately Emetogenic Chemotherapy (MEC)
T137	tradename 4765 4770	EMEND
T139	activeingredient 5235 5259	Fosaprepitant/Aprepitant
T141	activeingredient 5354 5364	Aprepitant
T143	indication 5775 5811	Highly Emetogenic Chemotherapy (HEC)
T145	indication 5812 5814	14
T147	indication 5817 5857	Moderately Emetogenic Chemotherapy (MEC)
T149	tradename 6075 6080	EMEND
T151	indication 6234 6285	prevention of acute and delayed nausea and vomiting
T153	indication 6332 6375	highly emetogenic cancer chemotherapy (HEC)
T155	indication 6445 6478	prevention of nausea and vomiting
T157	indication 6525 6572	moderately emetogenic cancer chemotherapy (MEC)
T159	tradename 6632 6637	EMEND
T161	indication 6853 6886	Prevention of Nausea and Vomiting
T163	indication 6903 6939	Highly Emetogenic Chemotherapy (HEC)
T165	tradename 6941 6946	EMEND
T167	dose 6961 6967	150 mg
T169	tradename 6992 6998	EMEND)
T171	tradename 7000 7005	EMEND
T173	dose 7020 7026	150 mg
T175	routeofadministration 7043 7056	intravenously
T177	tradename 7179 7184	EMEND
T179	tradename 7220 7225	EMEND
T181	co-administereddrug 7375 7388	dexamethasone
T183	tradename 7394 7399	EMEND
T185	dose 7414 7420	150 mg
T187	co-administereddrug 7460 7473	dexamethasone
T189	tradename 7479 7484	EMEND
T191	dose 7499 7505	115 mg
T193	tradename 7640 7645	EMEND
T195	tradename 7713 7719	EMEND)
T197	tradename 7842 7847	EMEND
T199	dose 7848 7854	150 mg
T201	routeofadministration 7855 7866	intravenous
T203	co-administereddrug 7883 7897	Dexamethasone*
T205	dose 7898 7903	12 mg
T207	routeofadministration 7904 7910	orally
T209	dose 7911 7915	8 mg
T211	routeofadministration 7916 7922	orally
T213	dose 7923 7927	8 mg
T215	routeofadministration 7928 7934	orally
T217	frequency 7935 7946	twice daily
T219	dose 7947 7951	8 mg
T221	routeofadministration 7952 7958	orally
T223	frequency 7959 7970	twice daily
T225	co-administereddrug 8099 8112	Dexamethasone
T227	co-administereddrug 8241 8254	dexamethasone
T229	tradename 8289 8294	EMEND
T231	dose 8309 8315	115 mg
T233	tradename 8341 8347	EMEND)
T235	tradename 8349 8354	EMEND
T237	dose 8369 8375	115 mg
T239	tradename 8494 8499	EMEND
T241	dose 8500 8505	80 mg
T243	tradename 8547 8552	EMEND
T245	dose 8567 8573	115 mg
T247	co-administereddrug 8709 8722	dexamethasone
T249	tradename 8728 8733	EMEND
T251	dose 8748 8754	115 mg
T253	co-administereddrug 8794 8807	dexamethasone
T255	tradename 8813 8818	EMEND
T257	dose 8833 8839	150 mg
T259	tradename 8974 8979	EMEND
T261	tradename 9008 9013	EMEND
T263	dose 9014 9020	125 mg
T265	tradename 9044 9049	EMEND
T267	dose 9064 9070	115 mg
T269	tradename 9135 9141	EMEND)
T271	indication 9150 9183	prevention of nausea and vomiting
T273	indication 9200 9237	highly emetogenic cancer chemotherapy
T275	tradename 9263 9268	EMEND
T277	dose 9269 9275	115 mg
T279	routeofadministration 9276 9287	intravenous
T281	dose 9288 9293	80 mg
T283	routeofadministration 9294 9300	orally
T285	dose 9301 9306	80 mg
T287	routeofadministration 9307 9313	orally
T289	co-administereddrug 9320 9334	Dexamethasone*
T291	dose 9335 9340	12 mg
T293	routeofadministration 9341 9347	orally
T295	dose 9348 9352	8 mg
T297	routeofadministration 9353 9359	orally
T299	dose 9360 9364	8 mg
T301	routeofadministration 9365 9371	orally
T303	frequency 9372 9382	once daily
T305	dose 9383 9387	8 mg
T307	routeofadministration 9388 9394	orally
T309	frequency 9395 9405	once daily
T311	co-administereddrug 9534 9547	Dexamethasone
T313	co-administereddrug 9676 9689	dexamethasone
T315	indication 9727 9760	Prevention of Nausea and Vomiting
T317	indication 9777 9817	Moderately Emetogenic Chemotherapy (MEC)
T319	tradename 9819 9824	EMEND
T321	dose 9839 9845	115 mg
T323	tradename 9871 9877	EMEND)
T325	tradename 9879 9884	EMEND
T327	dose 9899 9905	115 mg
T329	tradename 10024 10029	EMEND
T331	dose 10030 10035	80 mg
T333	tradename 10076 10081	EMEND
T335	dose 10096 10102	115 mg
T337	co-administereddrug 10238 10251	dexamethasone
T339	tradename 10257 10262	EMEND
T341	dose 10277 10283	115 mg
T343	co-administereddrug 10323 10336	dexamethasone
T345	tradename 10342 10347	EMEND
T347	dose 10362 10368	150 mg
T349	tradename 10503 10508	EMEND
T351	tradename 10537 10542	EMEND
T353	dose 10543 10549	125 mg
T355	tradename 10573 10578	EMEND
T357	dose 10593 10599	115 mg
T359	tradename 10663 10669	EMEND)
T361	indication 10678 10711	prevention of nausea and vomiting
T363	indication 10728 10769	moderately emetogenic cancer chemotherapy
T365	tradename 10790 10795	EMEND
T367	dose 10796 10802	115 mg
T369	routeofadministration 10803 10814	intravenous
T371	dose 10815 10820	80 mg
T373	routeofadministration 10821 10827	orally
T375	dose 10828 10833	80 mg
T377	routeofadministration 10834 10840	orally
T379	co-administereddrug 10841 10855	Dexamethasone*
T381	dose 10856 10861	12 mg
T383	routeofadministration 10862 10868	orally
T385	co-administereddrug 11001 11014	Dexamethasone
T387	co-administereddrug 11103 11116	dexamethasone
T389	tradename 11169 11174	EMEND
T391	tradename 11228 11233	EMEND
T393	dose 11249 11255	115 mg
T395	dose 11260 11267	150 mg)
T397	dose 11269 11282	115 mg 150 mg
T399	inactiveingredient 11321 11336	Sodium Chloride
T401	inactiveingredient 11359 11366	saline)
T403	inactiveingredient 11401 11407	saline
T405	inactiveingredient 11579 11594	Sodium Chloride
T407	inactiveingredient 11617 11624	saline)
T409	inactiveingredient 11881 11888	saline.
T411	inactiveingredient 11955 11962	saline.
T413	inactiveingredient 12091 12097	saline
T415	inactiveingredient 12292 12298	saline
T417	tradename 12808 12813	EMEND
T419	tradename 12954 12959	EMEND
T421	dose 13155 13161	150-mg
T423	routeofadministration 13256 13267	intravenous
T425	dose 13318 13324	115-mg
T427	routeofadministration 13419 13430	intravenous
T429	tradename 13519 13524	EMEND
T431	tradename 13596 13601	EMEND
T433	activeingredient 13618 13628	aprepitant
T435	inactiveingredient 13630 13644	polysorbate 80
T437	adversereaction 13727 13735	flushing
T439	adversereaction 13737 13745	erythema
T441	adversereaction 13747 13754	dyspnea
T443	adversereaction 13760 13782	anaphylactic reactions
T445	routeofadministration 13892 13898	orally
T447	activeingredient 14026 14039	fosaprepitant
T449	activeingredient 14064 14074	aprepitant
T451	activeingredient 14087 14100	fosaprepitant
T453	activeingredient 14167 14177	aprepitant
T455	activeingredient 14383 14396	Fosaprepitant
T457	activeingredient 14421 14431	aprepitant
T459	activeingredient 14539 14552	Fosaprepitant
T461	activeingredient 14698 14708	aprepitant
T463	activeingredient 14712 14725	fosaprepitant
T465	activeingredient 14813 14826	fosaprepitant
T467	activeingredient 14880 14890	aprepitant
T469	activeingredient 14938 14948	aprepitant
T471	activeingredient 15017 15027	aprepitant
T473	activeingredient 15113 15123	aprepitant
T475	activeingredient 15367 15377	aprepitant
T477	activeingredient 15688 15698	aprepitant
T479	adversereaction 16068 16094	Hypersensitivity Reactions
T481	adversereaction 16162 16170	flushing
T483	adversereaction 16172 16180	erythema
T485	adversereaction 16182 16189	dyspnea
T487	adversereaction 16196 16207	anaphylaxis
T489	activeingredient 16241 16255	fosaprepitant.
T491	co-administereddrug 16533 16541	Warfarin
T493	activeingredient 16584 16597	fosaprepitant
T495	activeingredient 16601 16611	aprepitant
T497	co-administereddrug 16617 16625	warfarin
T499	co-administereddrug 16759 16767	warfarin
T501	activeingredient 16889 16902	fosaprepitant
T503	co-administereddrug 16990 17013	Hormonal Contraceptives
T505	activeingredient 17041 17054	fosaprepitant
T507	activeingredient 17058 17068	aprepitant
T509	co-administereddrug 17086 17109	hormonal contraceptives
T511	activeingredient 17183 17196	fosaprepitant
T513	activeingredient 17200 17211	aprepitant.
T515	activeingredient 17340 17353	fosaprepitant
T517	activeingredient 17357 17367	aprepitant
T519	tradename 17453 17458	EMEND
T521	tradename 17980 17985	EMEND
T523	activeingredient 18016 18026	aprepitant
T525	activeingredient 18068 18078	aprepitant
T527	tradename 18116 18121	EMEND
T529	activeingredient 18160 18173	fosaprepitant
T531	activeingredient 18248 18258	aprepitant
T533	routeofadministration 18309 18313	Oral
T535	activeingredient 18314 18324	Aprepitant
T537	indication 18325 18361	Highly Emetogenic Chemotherapy (HEC)
T539	indication 18421 18458	highly emetogenic cancer chemotherapy
T541	activeingredient 18491 18501	aprepitant
T543	routeofadministration 18640 18644	Oral
T545	activeingredient 18645 18655	aprepitant
T547	co-administereddrug 18686 18697	ondansetron
T549	co-administereddrug 18702 18716	dexamethasone.
T551	activeingredient 18812 18822	aprepitant
T553	activeingredient 18996 19006	aprepitant
T555	activeingredient 19150 19160	aprepitant
T557	indication 19320 19323	HEC
T559	activeingredient 19357 19367	Aprepitant
T561	activeingredient 19405 19415	Aprepitant
T563	adversereaction 19476 19483	hiccups
T565	adversereaction 19525 19541	asthenia/fatigue
T567	adversereaction 19565 19578	ALT increased
T569	adversereaction 19587 19600	AST increased
T571	adversereaction 19626 19638	constipation
T573	adversereaction 19647 19656	dyspepsia
T575	adversereaction 19665 19673	diarrhea
T577	adversereaction 19697 19705	headache
T579	adversereaction 19739 19747	anorexia
T581	activeingredient 19795 19805	aprepitant
T583	activeingredient 20039 20049	aprepitant
T585	indication 20165 20168	HEC
T587	activeingredient 20182 20193	aprepitant.
T589	indication 20195 20235	Moderately Emetogenic Chemotherapy (MEC)
T591	indication 20236 20238	In
T593	indication 20295 20336	moderately emetogenic cancer chemotherapy
T595	activeingredient 20373 20383	aprepitant
T597	activeingredient 20534 20544	aprepitant
T599	co-administereddrug 20575 20586	ondansetron
T601	co-administereddrug 20591 20604	dexamethasone
T603	activeingredient 20606 20616	aprepitant
T605	activeingredient 20772 20782	aprepitant
T607	activeingredient 20956 20966	aprepitant
T609	activeingredient 21110 21120	aprepitant
T611	indication 21292 21295	MEC
T613	activeingredient 21328 21338	Aprepitant
T615	activeingredient 21376 21386	Aprepitant
T617	adversereaction 21456 21466	eructation
T619	adversereaction 21529 21536	fatigue
T621	activeingredient 21584 21594	aprepitant
T623	indication 21819 21822	HEC
T625	indication 21826 21829	MEC
T627	activeingredient 21867 21877	aprepitant
T629	indication 22047 22050	HEC
T631	indication 22054 22057	MEC
T633	activeingredient 22099 22109	Aprepitant
T635	adversereaction 22174 22185	candidiasis
T637	adversereaction 22187 22211	staphylococcal infection
T639	adversereaction 22253 22259	anemia
T641	adversereaction 22261 22280	febrile neutropenia
T643	adversereaction 22316 22327	weight gain
T645	adversereaction 22329 22339	polydipsia
T647	adversereaction 22363 22377	disorientation
T649	adversereaction 22379 22387	euphoria
T651	adversereaction 22389 22396	anxiety
T653	adversereaction 22397 22404	Nervous
T655	adversereaction 22422 22431	dizziness
T657	adversereaction 22433 22450	dream abnormality
T659	adversereaction 22452 22470	cognitive disorder
T661	adversereaction 22472 22480	lethargy
T663	adversereaction 22482 22492	somnolence
T665	adversereaction 22508 22522	conjunctivitis
T667	adversereaction 22523 22526	Ear
T669	adversereaction 22551 22559	tinnitus
T671	adversereaction 22579 22590	bradycardia
T673	adversereaction 22592 22615	cardiovascular disorder
T675	adversereaction 22617 22629	palpitations
T677	adversereaction 22630 22638	Vascular
T679	adversereaction 22649 22658	hot flush
T681	adversereaction 22660 22668	flushing
T683	adversereaction 22669 22680	Respiratory
T685	adversereaction 22718 22729	pharyngitis
T687	adversereaction 22731 22739	sneezing
T689	adversereaction 22741 22746	cough
T691	adversereaction 22748 22762	postnasal drip
T693	adversereaction 22764 22781	throat irritation
T695	adversereaction 22811 22817	nausea
T697	adversereaction 22819 22830	acid reflux
T699	adversereaction 22832 22841	dysgeusia
T701	adversereaction 22843 22864	epigastric discomfort
T703	adversereaction 22866 22877	obstipation
T705	adversereaction 22879 22910	gastroesophageal reflux disease
T707	adversereaction 22912 22938	perforating duodenal ulcer
T709	adversereaction 22940 22948	vomiting
T711	adversereaction 22950 22964	abdominal pain
T713	adversereaction 22966 22975	dry mouth
T715	adversereaction 22977 22997	abdominal distension
T717	adversereaction 22999 23010	faeces hard
T719	adversereaction 23012 23031	neutropenic colitis
T721	adversereaction 23033 23043	flatulence
T723	adversereaction 23045 23055	stomatitis
T725	adversereaction 23097 23101	rash
T727	adversereaction 23103 23107	acne
T729	adversereaction 23109 23125	photosensitivity
T731	adversereaction 23127 23140	hyperhidrosis
T733	adversereaction 23142 23151	oily skin
T735	adversereaction 23153 23161	pruritus
T737	adversereaction 23163 23174	skin lesion
T739	adversereaction 23225 23237	muscle cramp
T741	adversereaction 23239 23246	myalgia
T743	adversereaction 23248 23265	muscular weakness
T745	adversereaction 23295 23303	polyuria
T747	adversereaction 23305 23312	dysuria
T749	adversereaction 23314 23325	pollakiuria
T751	adversereaction 23380 23385	edema
T753	adversereaction 23387 23403	chest discomfort
T755	adversereaction 23405 23412	malaise
T757	adversereaction 23414 23420	thirst
T759	adversereaction 23422 23428	chills
T761	adversereaction 23430 23446	gait disturbance
T763	adversereaction 23463 23493	alkaline phosphatase increased
T765	adversereaction 23495 23508	hyperglycemia
T767	adversereaction 23510 23531	microscopic hematuria
T769	adversereaction 23533 23545	hyponatremia
T771	adversereaction 23547 23563	weight decreased
T773	adversereaction 23565 23591	neutrophil count decreased
T775	adversereaction 23659 23683	Stevens-Johnson syndrome
T777	activeingredient 23750 23760	aprepitant
T779	indication 23856 23859	HEC
T781	indication 23864 23867	MEC
T783	activeingredient 23954 23967	Fosaprepitant
T785	activeingredient 23968 23970	In
T787	indication 24029 24059	highly emetogenic chemotherapy
T789	tradename 24132 24137	EMEND
T791	dose 24152 24158	150 mg
T793	tradename 24216 24221	EMEND
T795	activeingredient 24223 24234	aprepitant)
T797	indication 24300 24303	HEC
T799	activeingredient 24317 24328	aprepitant.
T801	activeingredient 24412 24425	fosaprepitant
T803	activeingredient 24464 24474	aprepitant
T805	adversereaction 24536 24558	infusion-site erythema
T807	adversereaction 24560 24582	infusion-site pruritus
T809	adversereaction 24584 24602	infusion-site pain
T811	adversereaction 24604 24628	infusion-site induration
T813	adversereaction 24634 24665	infusion-site thrombophlebitis.
T815	activeingredient 24724 24737	fosaprepitant
T817	dose 24738 24744	150 mg
T819	routeofadministration 24776 24780	oral
T821	activeingredient 24781 24791	aprepitant
T823	activeingredient 24907 24920	Fosaprepitant
T825	dose 24921 24927	150 mg
T827	routeofadministration 24960 24964	Oral
T829	activeingredient 24965 24975	Aprepitant
T831	adversereaction 25037 25059	infusion site erythema
T833	adversereaction 25061 25083	infusion site pruritus
T835	adversereaction 25085 25109	infusion site induration
T837	adversereaction 25111 25129	infusion site pain
T839	adversereaction 25146 25170	blood pressure increased
T841	adversereaction 25171 25175	Skin
T843	adversereaction 25210 25218	erythema
T845	adversereaction 25239 25255	thrombophlebitis
T847	adversereaction 25272 25303	infusion-site thrombophlebitis)
T849	dose 25476 25481	40-mg
T851	activeingredient 25482 25492	aprepitant
T853	routeofadministration 25493 25499	orally
T855	dose 25535 25539	4-mg
T857	co-administereddrug 25540 25551	ondansetron
T859	routeofadministration 25552 25566	intravenously.
T861	dose 25645 25650	40-mg
T863	activeingredient 25651 25661	aprepitant
T865	dose 25718 25722	4-mg
T867	co-administereddrug 25723 25734	ondansetron
T869	routeofadministration 25735 25749	intravenously.
T871	activeingredient 25776 25786	aprepitant
T873	adversereaction 25788 25801	increased ALT
T875	co-administereddrug 25851 25862	ondansetron
T877	activeingredient 25954 25964	aprepitant
T879	co-administereddrug 26010 26022	ondansetron.
T881	activeingredient 26091 26101	Aprepitant
T883	dose 26102 26107	40 mg
T885	activeingredient 26140 26150	Aprepitant
T887	co-administereddrug 26169 26180	ondansetron
T889	co-administereddrug 26181 26192	Psychiatric
T891	adversereaction 26203 26211	insomnia
T893	adversereaction 26212 26219	Nervous
T895	adversereaction 26237 26247	dysarthria
T897	adversereaction 26249 26261	hypoesthesia
T899	adversereaction 26263 26282	sensory disturbance
T901	adversereaction 26283 26286	Eye
T903	adversereaction 26297 26303	miosis
T905	adversereaction 26305 26326	visual acuity reduced
T907	adversereaction 26327 26334	Cardiac
T909	adversereaction 26345 26356	bradycardia
T911	adversereaction 26357 26368	Respiratory
T913	adversereaction 26405 26412	dyspnea
T915	adversereaction 26414 26422	wheezing
T917	adversereaction 26451 26471	abdominal pain upper
T919	adversereaction 26473 26494	bowel sounds abnormal
T921	adversereaction 26496 26505	dry mouth
T923	adversereaction 26507 26513	nausea
T925	adversereaction 26515 26533	stomach discomfort
T927	activeingredient 26689 26700	aprepitant:
T929	adversereaction 26768 26778	Angioedema
T931	adversereaction 26783 26792	urticaria
T933	activeingredient 26859 26869	aprepitant
T935	activeingredient 27011 27024	fosaprepitant
T937	activeingredient 27029 27040	aprepitant.
T939	adversereaction 27286 27294	pruritus
T941	adversereaction 27296 27300	rash
T943	adversereaction 27302 27311	urticaria
T945	adversereaction 27320 27372	Stevens-Johnson syndrome/toxic epidermal necrolysis.
T947	adversereaction 27399 27425	hypersensitivity reactions
T949	adversereaction 27436 27459	anaphylactic reactions.
T951	adversereaction 27496 27528	ifosfamide-induced neurotoxicity
T953	activeingredient 27555 27565	aprepitant
T955	co-administereddrug 27570 27580	ifosfamide
T957	activeingredient 27667 27680	fosaprepitant
T959	routeofadministration 27731 27735	oral
T961	activeingredient 27736 27747	aprepitant.
T963	activeingredient 27749 27759	Aprepitant
T965	activeingredient 27888 27898	Aprepitant
T967	activeingredient 27930 27943	Fosaprepitant
T969	dose 27944 27950	150 mg
T971	activeingredient 28035 28048	Fosaprepitant
T973	activeingredient 28052 28062	aprepitant
T975	routeofadministration 28208 28212	oral
T977	activeingredient 28213 28223	aprepitant
T979	activeingredient 28252 28265	fosaprepitant
T981	routeofadministration 28270 28274	oral
T983	activeingredient 28315 28328	fosaprepitant
T985	activeingredient 28364 28388	Fosaprepitant/Aprepitant
T987	activeingredient 28449 28459	Aprepitant
T989	activeingredient 28500 28513	fosaprepitant
T991	dose 28514 28520	150 mg
T993	routeofadministration 28620 28624	oral
T995	activeingredient 28760 28770	aprepitant
T997	co-administereddrug 28840 28851	ondansetron
T999	co-administereddrug 28853 28864	granisetron
T1001	co-administereddrug 28869 28884	hydrodolasetron
T1003	co-administereddrug 28942 28956	Dexamethasone:
T1005	activeingredient 28957 28970	Fosaprepitant
T1007	dose 28971 28977	150 mg
T1009	routeofadministration 29003 29014	intravenous
T1011	co-administereddrug 29056 29069	dexamethasone
T1013	dose 29096 29100	8-mg
T1015	routeofadministration 29101 29105	oral
T1017	routeofadministration 29178 29182	oral
T1019	co-administereddrug 29183 29196	dexamethasone
T1021	activeingredient 29282 29295	fosaprepitant
T1023	dose 29296 29302	150-mg
T1025	routeofadministration 29303 29314	intravenous
T1027	routeofadministration 29329 29333	oral
T1029	activeingredient 29334 29344	aprepitant
T1031	dose 29356 29362	125 mg
T1033	dose 29377 29382	80 mg
T1035	frequency 29382 29386	/day
T1037	dose 29428 29433	20-mg
T1039	routeofadministration 29434 29438	oral
T1041	co-administereddrug 29439 29452	dexamethasone
T1043	routeofadministration 29471 29475	oral
T1045	co-administereddrug 29476 29489	dexamethasone
T1047	co-administereddrug 29532 29545	dexamethasone
T1049	routeofadministration 29579 29583	oral
T1051	co-administereddrug 29584 29597	dexamethasone
T1053	activeingredient 29681 29694	fosaprepitant
T1055	dose 29695 29701	115 mg
T1057	activeingredient 29714 29725	aprepitant.
T1059	co-administereddrug 29728 29747	Methylprednisolone:
T1061	routeofadministration 29751 29755	oral
T1063	activeingredient 29756 29766	aprepitant
T1065	dose 29778 29784	125 mg
T1067	dose 29798 29803	80 mg
T1069	frequency 29803 29807	/day
T1071	co-administereddrug 29845 29863	methylprednisolone
T1073	co-administereddrug 29917 29935	methylprednisolone
T1075	routeofadministration 29955 29968	intravenously
T1077	dose 29972 29978	125 mg
T1079	routeofadministration 29992 29998	orally
T1081	dose 30002 30007	40 mg
T1083	routeofadministration 30029 30040	intravenous
T1085	co-administereddrug 30041 30059	methylprednisolone
T1087	routeofadministration 30113 30117	oral
T1089	co-administereddrug 30118 30136	methylprednisolone
T1091	activeingredient 30232 30232	
T1093	dose 30233 30239	115 mg
T1095	activeingredient 30252 30263	aprepitant.
T1097	co-administereddrug 30290 30300	Docetaxel:
T1099	routeofadministration 30329 30333	oral
T1101	activeingredient 30334 30344	aprepitant
T1103	co-administereddrug 30403 30413	docetaxel.
T1105	co-administereddrug 30415 30427	Vinorelbine:
T1107	routeofadministration 30456 30460	oral
T1109	activeingredient 30461 30471	aprepitant
T1111	co-administereddrug 30529 30540	vinorelbine
T1113	tradename 30609 30614	EMEND
T1115	routeofadministration 30849 30853	oral
T1117	activeingredient 30854 30864	aprepitant
T1119	co-administereddrug 30866 30877	ondansetron
T1121	co-administereddrug 30883 30896	dexamethasone
T1123	routeofadministration 30925 30929	oral
T1125	activeingredient 31146 31159	fosaprepitant
T1127	activeingredient 31163 31173	aprepitant
T1129	co-administereddrug 31201 31224	hormonal contraceptives
T1131	activeingredient 31371 31384	fosaprepitant
T1133	activeingredient 31388 31399	aprepitant.
T1135	activeingredient 31529 31542	fosaprepitant
T1137	activeingredient 31546 31557	aprepitant.
T1139	co-administereddrug 31559 31569	Midazolam:
T1141	activeingredient 31591 31601	aprepitant
T1143	activeingredient 31605 31618	fosaprepitant
T1145	co-administereddrug 31638 31647	midazolam
T1147	activeingredient 31792 31816	Fosaprepitant/Aprepitant
T1149	co-administereddrug 31837 31846	Midazolam
T1151	co-administereddrug 31847 31851	Dose
T1153	activeingredient 31855 31880	fosaprepitant/ aprepitant
T1155	activeingredient 31881 31885	Dose
T1157	co-administereddrug 31889 31898	Midazolam
T1159	co-administereddrug 31899 31907	Observed
T1161	activeingredient 31927 31940	fosaprepitant
T1163	dose 31941 31947	150 mg
T1165	routeofadministration 31958 31962	oral
T1167	dose 31963 31967	2 mg
T1169	activeingredient 32028 32041	fosaprepitant
T1171	dose 32042 32048	100 mg
T1173	routeofadministration 32059 32063	oral
T1175	dose 32064 32068	2 mg
T1177	routeofadministration 32069 32073	oral
T1179	co-administereddrug 32074 32083	midazolam
T1181	routeofadministration 32100 32104	oral
T1183	activeingredient 32105 32115	aprepitant
T1185	dose 32116 32122	125 mg
T1187	dose 32136 32141	80 mg
T1189	routeofadministration 32158 32162	oral
T1191	dose 32163 32167	2 mg
T1193	routeofadministration 32188 32192	oral
T1195	co-administereddrug 32193 32202	midazolam
T1197	routeofadministration 32252 32256	oral
T1199	activeingredient 32257 32267	aprepitant
T1201	dose 32268 32274	125 mg
T1203	dose 32288 32293	80 mg
T1205	routeofadministration 32311 32322	intravenous
T1207	dose 32323 32327	2 mg
T1209	activeingredient 32354 32364	aprepitant
T1211	routeofadministration 32390 32401	intravenous
T1213	co-administereddrug 32402 32411	midazolam
T1215	routeofadministration 32475 32479	oral
T1217	activeingredient 32480 32490	aprepitant
T1219	dose 32491 32497	125 mg
T1221	routeofadministration 32498 32509	intravenous
T1223	dose 32510 32514	2 mg
T1225	activeingredient 32534 32544	aprepitant
T1227	routeofadministration 32546 32557	intravenous
T1229	co-administereddrug 32558 32567	midazolam
T1231	co-administereddrug 32629 32638	midazolam
T1233	co-administereddrug 32745 32754	midazolam
T1235	co-administereddrug 32804 32814	alprazolam
T1237	co-administereddrug 32816 32826	triazolam)
T1239	activeingredient 32887 32900	fosaprepitant
T1241	activeingredient 32904 32915	aprepitant.
T1243	co-administereddrug 32936 32944	Warfarin
T1245	co-administereddrug 32946 32958	Tolbutamide)
T1247	co-administereddrug 32960 32969	Warfarin:
T1249	dose 32979 32985	125-mg
T1251	routeofadministration 32994 32998	oral
T1253	activeingredient 32999 33009	aprepitant
T1255	dose 33040 33045	80 mg
T1257	frequency 33045 33049	/day
T1259	co-administereddrug 33117 33125	warfarin
T1261	routeofadministration 33168 33172	oral
T1263	activeingredient 33173 33183	aprepitant
T1265	co-administereddrug 33218 33226	warfarin
T1267	co-administereddrug 33281 33289	warfarin
T1269	routeofadministration 33456 33460	oral
T1271	activeingredient 33461 33472	aprepitant.
T1273	co-administereddrug 33497 33505	warfarin
T1275	activeingredient 33646 33659	fosaprepitant
T1277	co-administereddrug 33691 33703	Tolbutamide:
T1279	routeofadministration 33704 33708	Oral
T1281	activeingredient 33709 33719	aprepitant
T1283	dose 33735 33741	125 mg
T1285	dose 33755 33760	80 mg
T1287	frequency 33760 33764	/day
T1289	co-administereddrug 33803 33814	tolbutamide
T1291	co-administereddrug 33887 33898	tolbutamide
T1293	dose 33899 33905	500 mg
T1295	routeofadministration 33923 33929	orally
T1297	routeofadministration 33982 33986	oral
T1299	activeingredient 33987 33997	aprepitant
T1301	activeingredient 34080 34090	Aprepitant
T1303	activeingredient 34091 34101	Aprepitant
T1305	activeingredient 34160 34173	fosaprepitant
T1307	activeingredient 34177 34187	aprepitant
T1309	activeingredient 34277 34288	aprepitant.
T1311	activeingredient 34334 34347	fosaprepitant
T1313	activeingredient 34351 34361	aprepitant
T1315	co-administereddrug 34399 34411	ketoconazole
T1317	co-administereddrug 34413 34425	itraconazole
T1319	co-administereddrug 34427 34437	nefazodone
T1321	co-administereddrug 34439 34453	troleandomycin
T1323	co-administereddrug 34455 34469	clarithromycin
T1325	co-administereddrug 34471 34480	ritonavir
T1327	co-administereddrug 34482 34493	nelfinavir)
T1329	activeingredient 34639 34649	aprepitant
T1331	activeingredient 34719 34729	Aprepitant
T1333	activeingredient 34788 34801	fosaprepitant
T1335	activeingredient 34805 34815	aprepitant
T1337	co-administereddrug 34976 34989	Ketoconazole:
T1339	dose 35004 35010	125-mg
T1341	routeofadministration 35019 35023	oral
T1343	activeingredient 35024 35034	aprepitant
T1345	dose 35084 35090	400 mg
T1347	frequency 35090 35094	/day
T1349	co-administereddrug 35098 35110	ketoconazole
T1351	activeingredient 35150 35160	aprepitant
T1353	activeingredient 35227 35237	aprepitant
T1355	activeingredient 35301 35314	fosaprepitant
T1357	activeingredient 35318 35328	aprepitant
T1359	co-administereddrug 35393 35402	Rifampin:
T1361	dose 35417 35423	375-mg
T1363	routeofadministration 35432 35436	oral
T1365	activeingredient 35437 35447	aprepitant
T1367	dose 35497 35503	600 mg
T1369	frequency 35503 35507	/day
T1371	co-administereddrug 35511 35519	rifampin
T1373	activeingredient 35557 35567	aprepitant
T1375	activeingredient 35685 35698	fosaprepitant
T1377	activeingredient 35702 35712	aprepitant
T1379	co-administereddrug 35849 35859	Diltiazem:
T1381	routeofadministration 35922 35933	intravenous
T1383	dose 35946 35952	100 mg
T1385	activeingredient 35956 35969	fosaprepitant
T1387	co-administereddrug 35975 35984	diltiazem
T1389	dose 35985 35991	120 mg
T1391	activeingredient 36042 36052	aprepitant
T1393	co-administereddrug 36084 36093	diltiazem
T1395	activeingredient 36246 36259	fosaprepitant
T1397	activeingredient 36307 36308	]
T1399	activeingredient 36471 36485	fosaprepitant]
T1401	co-administereddrug 36646 36655	diltiazem
T1403	activeingredient 36701 36711	aprepitant
T1405	dose 36762 36768	230 mg
T1407	co-administereddrug 36802 36811	diltiazem
T1409	dose 36812 36818	120 mg
T1411	frequency 36819 36832	3 times daily
T1413	activeingredient 36878 36888	aprepitant
T1415	co-administereddrug 36933 36942	diltiazem
T1417	co-administereddrug 37096 37105	diltiazem
T1419	co-administereddrug 37114 37125	Paroxetine:
T1421	frequency 37146 37156	once daily
T1423	activeingredient 37166 37176	aprepitant
T1425	dose 37216 37221	85 mg
T1427	dose 37225 37231	170 mg
T1429	co-administereddrug 37265 37275	paroxetine
T1431	dose 37276 37281	20 mg
T1433	frequency 37282 37292	once daily
T1435	activeingredient 37383 37393	aprepitant
T1437	co-administereddrug 37398 37409	paroxetine.
T1439	activeingredient 37541 37554	fosaprepitant
T1441	activeingredient 37559 37569	aprepitant
T1443	activeingredient 37605 37615	aprepitant
T1445	routeofadministration 37640 37644	oral
T1447	activeingredient 37663 37674	aprepitant.
T1449	routeofadministration 37717 37721	oral
T1451	activeingredient 37731 37741	aprepitant
T1453	dose 37748 37758	1000 mg/kg
T1455	frequency 37759 37770	twice daily
T1457	auc 37792 37812	31.3 &#x20ac; hr/mL
T1459	dose 37909 37917	25 mg/kg
T1461	frequency 37917 37921	/day
T1463	auc 37943 37963	26.9 &#x20ac; hr/mL
T1465	activeingredient 38096 38107	aprepitant.
T1467	activeingredient 38357 38367	Aprepitant
T1469	activeingredient 38600 38610	aprepitant
T1471	activeingredient 38669 38679	aprepitant
T1473	tradename 38909 38914	EMEND
T1475	routeofadministration 39131 39135	oral
T1477	activeingredient 39136 39146	aprepitant
T1479	activeingredient 39666 39679	fosaprepitant
T1481	activeingredient 39683 39693	aprepitant
T1483	activeingredient 39849 39862	fosaprepitant
T1485	activeingredient 39866 39877	aprepitant.
T1487	activeingredient 39904 39917	fosaprepitant
T1489	routeofadministration 39925 39929	oral
T1491	activeingredient 39930 39940	aprepitant
T1493	activeingredient 40070 40080	aprepitant
T1495	activeingredient 40125 40135	Aprepitant
T1497	tradename 40228 40233	EMEND
T1499	activeingredient 40262 40275	fosaprepitant
T1501	dose 40276 40282	150 mg
T1503	routeofadministration 40308 40312	oral
T1505	activeingredient 40313 40323	aprepitant
T1507	dose 40325 40331	125 mg
T1509	dose 40335 40341	80 mg.
T1511	tradename 40473 40478	EMEND
T1513	nanoparticle 40480 40506	fosaprepitant dimeglumine)
T1515	activeingredient 40558 40568	aprepitant
T1517	nanoparticle 40954 40979	Fosaprepitant dimeglumine
T1519	molecularweight 41048 41056	1004.83.
T1521	tradename 41089 41094	EMEND
T1523	activeingredient 41137 41147	aprepitant
T1525	inactiveingredient 41159 41180	polysorbate 80 (PS80)
T1527	routeofadministration 41201 41214	intravenously
T1529	tradename 41245 41250	EMEND
T1531	dose 41265 41271	115 mg
T1533	routeofadministration 41276 41287	intravenous
T1535	dose 41312 41318	188 mg
T1537	nanoparticle 41322 41347	fosaprepitant dimeglumine
T1539	dose 41362 41368	115 mg
T1541	activeingredient 41372 41385	fosaprepitant
T1543	inactiveingredient 41436 41452	edetate disodium
T1545	inactiveingredient 41464 41478	polysorbate 80
T1547	inactiveingredient 41490 41507	lactose anhydrous
T1549	inactiveingredient 41520 41536	sodium hydroxide
T1551	inactiveingredient 41544 41561	hydrochloric acid
T1553	tradename 41597 41602	EMEND
T1555	dose 41617 41623	150 mg
T1557	routeofadministration 41628 41639	intravenous
T1559	dose 41664 41672	245.3 mg
T1561	nanoparticle 41676 41701	fosaprepitant dimeglumine
T1563	dose 41716 41722	150 mg
T1565	activeingredient 41726 41739	fosaprepitant
T1567	inactiveingredient 41790 41806	edetate disodium
T1569	inactiveingredient 41818 41832	polysorbate 80
T1571	inactiveingredient 41842 41859	lactose anhydrous
T1573	inactiveingredient 41870 41886	sodium hydroxide
T1575	inactiveingredient 41894 41911	hydrochloric acid
T1577	nanoparticle 41934 41959	Fosaprepitant dimeglumine
T1579	activeingredient 41993 42007	fosaprepitant.
T1581	activeingredient 42035 42048	Fosaprepitant
T1583	activeingredient 42063 42073	aprepitant
T1585	routeofadministration 42093 42106	intravenously
T1587	activeingredient 42131 42141	aprepitant
T1589	activeingredient 42222 42235	fosaprepitant
T1591	dose 42390 42396	188 mg
T1593	nanoparticle 42400 42425	fosaprepitant dimeglumine
T1595	dose 42441 42447	115-mg
T1597	activeingredient 42448 42461	fosaprepitant
T1599	activeingredient 42476 42486	aprepitant
T1601	dose 42573 42581	245.3 mg
T1603	nanoparticle 42585 42610	fosaprepitant dimeglumine
T1605	dose 42626 42632	150-mg
T1607	activeingredient 42633 42646	fosaprepitant
T1609	activeingredient 42661 42671	aprepitant
T1611	activeingredient 42766 42779	Fosaprepitant
T1613	activeingredient 42796 42806	aprepitant
T1615	activeingredient 42867 42878	aprepitant.
T1617	activeingredient 42880 42890	Aprepitant
T1619	activeingredient 42983 42993	Aprepitant
T1621	activeingredient 43171 43181	Aprepitant
T1623	activeingredient 43384 43394	aprepitant
T1625	activeingredient 43516 43526	aprepitant
T1627	routeofadministration 43869 43873	oral
T1629	activeingredient 43874 43884	aprepitant
T1631	dose 43894 43899	10 mg
T1633	dose 43907 43912	30 mg
T1635	dose 43920 43926	100 mg
T1637	dose 43936 43942	300 mg
T1639	frequency 43949 43959	once daily
T1641	duration 43964 43971	14 days
T1643	activeingredient 44018 44028	aprepitant
T1645	activeingredient 44189 44199	aprepitant
T1647	routeofadministration 44319 44323	oral
T1649	activeingredient 44324 44334	aprepitant
T1651	activeingredient 44380 44390	aprepitant
T1653	activeingredient 44735 44745	aprepitant
T1655	dose 44880 44886	200-mg
T1657	activeingredient 44895 44908	fosaprepitant
T1659	activeingredient 44967 44977	Aprepitant
T1661	activeingredient 44984 44997	Fosaprepitant
T1663	routeofadministration 45033 45044	intravenous
T1665	dose 45045 45051	115-mg
T1667	activeingredient 45060 45073	fosaprepitant
T1669	activeingredient 45159 45169	aprepitant
T1671	auc 45174 45203	31.7 ( 14.3) &#x20ac; hr/mL
T1673	activeingredient 45225 45235	aprepitant
T1675	cmax 45261 45282	3.27 ( 1.16) mcg/mL.
T1677	activeingredient 45292 45302	aprepitant
T1679	dose 45369 45375	125-mg
T1681	routeofadministration 45376 45380	oral
T1683	activeingredient 45381 45391	aprepitant
T1685	dose 45405 45411	115-mg
T1687	routeofadministration 45412 45423	intravenous
T1689	activeingredient 45424 45437	fosaprepitant
T1691	activeingredient 45501 45511	Aprepitant
T1693	dose 45522 45528	125-mg
T1695	routeofadministration 45529 45533	Oral
T1697	activeingredient 45534 45544	Aprepitant
T1699	dose 45549 45555	115-mg
T1701	routeofadministration 45556 45567	Intravenous
T1703	activeingredient 45568 45581	Fosaprepitant
T1705	routeofadministration 45603 45614	intravenous
T1707	dose 45615 45621	150-mg
T1709	activeingredient 45630 45643	fosaprepitant
T1711	activeingredient 45730 45740	aprepitant
T1713	auc 45745 45776	37.38 ( 14.75) &#x20ac; hr/mL
T1715	activeingredient 45798 45808	aprepitant
T1717	cmax 45834 45855	4.15 ( 1.15) mcg/mL.
T1719	activeingredient 45870 45883	Fosaprepitant
T1721	activeingredient 45908 45930	aprepitant. Aprepitant
T1723	volumeofdistribution 46059 46063	70 L
T1725	activeingredient 46076 46086	Aprepitant
T1727	activeingredient 46222 46235	Fosaprepitant
T1729	activeingredient 46261 46271	aprepitant
T1731	activeingredient 46385 46398	fosaprepitant
T1733	activeingredient 46449 46459	aprepitant
T1735	activeingredient 46588 46601	fosaprepitant
T1737	activeingredient 46605 46615	aprepitant
T1739	activeingredient 46697 46710	fosaprepitant
T1741	routeofadministration 46724 46737	intravenously
T1743	activeingredient 46763 46773	aprepitant
T1745	activeingredient 46824 46834	Aprepitant
T1747	activeingredient 46927 46937	aprepitant
T1749	activeingredient 47181 47191	aprepitant
T1751	routeofadministration 47287 47291	oral
T1753	dose 47292 47298	300-mg
T1755	activeingredient 47313 47323	aprepitant
T1757	activeingredient 47411 47421	aprepitant
T1759	routeofadministration 47540 47551	intravenous
T1761	dose 47552 47558	100-mg
T1763	activeingredient 47573 47586	fosaprepitant
T1765	activeingredient 47675 47685	Aprepitant
T1767	activeingredient 47725 47735	aprepitant
T1769	plasmahalflife 47819 47833	9 to 13 hours.
T1771	routeofadministration 47875 47879	oral
T1773	activeingredient 47915 47925	aprepitant
T1775	activeingredient 48026 48036	aprepitant
T1777	dose 48297 48303	125-mg
T1779	activeingredient 48312 48322	aprepitant
T1781	dose 48336 48341	80 mg
T1783	frequency 48342 48352	once daily
T1785	activeingredient 48391 48401	aprepitant
T1787	routeofadministration 48739 48743	oral
T1789	activeingredient 48779 48789	aprepitant
T1791	activeingredient 49245 49255	aprepitant
T1793	activeingredient 49466 49479	Fosaprepitant
T1795	activeingredient 49600 49613	fosaprepitant
T1797	activeingredient 49617 49628	aprepitant.
T1799	dose 49666 49672	125-mg
T1801	routeofadministration 49681 49685	oral
T1803	activeingredient 49686 49696	aprepitant
T1805	dose 49710 49715	80 mg
T1807	activeingredient 49828 49838	aprepitant
T1809	activeingredient 50033 50043	aprepitant
T1811	dose 50510 50516	240-mg
T1813	routeofadministration 50525 50529	oral
T1815	activeingredient 50530 50540	aprepitant
T1817	activeingredient 50842 50852	aprepitant
T1819	activeingredient 51103 51113	aprepitant
T1821	activeingredient 51205 51215	aprepitant
T1823	activeingredient 51498 51508	aprepitant
T1825	routeofadministration 51931 51935	oral
T1827	dose 51955 51973	0.05 to 1000 mg/kg
T1829	frequency 51974 51986	twice daily.
T1831	activeingredient 52037 52047	aprepitant
T1833	auc 52119 52140	19.6 &#x20ac; hr/mL)
T1835	dose 52168 52174	125 mg
T1837	frequency 52174 52179	/day.
T1839	activeingredient 52196 52206	aprepitant
T1841	dose 52219 52234	5 to 1000 mg/kg
T1843	frequency 52235 52246	twice daily
T1845	dose 52404 52419	5 to 1000 mg/kg
T1847	frequency 52420 52431	twice daily
T1849	dose 52502 52519	125 to 1000 mg/kg
T1851	frequency 52520 52532	twice daily.
T1853	routeofadministration 52602 52606	oral
T1855	dose 52626 52643	2.5 to 2000 mg/kg
T1857	frequency 52643 52648	/day.
T1859	activeingredient 52782 52792	aprepitant
T1861	dose 52824 52841	125 and 500 mg/kg
T1863	frequency 52841 52845	/day
T1865	activeingredient 52915 52929	fosaprepitant.
T1867	activeingredient 52931 52941	Aprepitant
T1869	activeingredient 52946 52959	fosaprepitant
T1871	activeingredient 53191 53204	Fosaprepitant
T1873	routeofadministration 53224 53237	intravenously
T1875	activeingredient 53263 53274	aprepitant.
T1877	activeingredient 53316 53329	fosaprepitant
T1879	activeingredient 53334 53344	aprepitant
T1881	activeingredient 53380 53390	aprepitant
T1883	routeofadministration 53415 53419	oral
T1885	activeingredient 53438 53449	aprepitant.
T1887	routeofadministration 53451 53455	Oral
T1889	activeingredient 53456 53466	aprepitant
T1891	dose 53599 53609	1000 mg/kg
T1893	frequency 53610 53621	twice daily
T1895	activeingredient 53799 53812	Fosaprepitant
T1897	activeingredient 53827 53837	aprepitant
T1899	routeofadministration 53857 53870	intravenously
T1901	activeingredient 53895 53906	aprepitant.
T1903	routeofadministration 53908 53912	Oral
T1905	activeingredient 53931 53941	aprepitant
T1907	co-administereddrug 53962 53973	ondansetron
T1909	co-administereddrug 53978 53991	dexamethasone
T1911	activeingredient 53993 54003	aprepitant
T1913	indication 54031 54076	prevent acute and delayed nausea and vomiting
T1915	indication 54093 54123	highly emetogenic chemotherapy
T1917	indication 54237 54273	Highly Emetogenic Chemotherapy (HEC)
T1919	tradename 54274 54279	EMEND
T1921	dose 54294 54300	115 mg
T1923	tradename 54326 54332	EMEND)
T1925	activeingredient 54334 54347	Fosaprepitant
T1927	dose 54348 54354	115 mg
T1929	routeofadministration 54355 54366	intravenous
T1931	dose 54414 54420	125 mg
T1933	routeofadministration 54421 54425	oral
T1935	activeingredient 54426 54436	aprepitant
T1937	routeofadministration 54526 54530	oral
T1939	activeingredient 54531 54542	aprepitant.
T1941	activeingredient 54631 54641	aprepitant
T1943	co-administereddrug 54759 54768	cisplatin
T1945	dose 54769 54781	&gt;50 mg/m2
T1947	co-administereddrug 54788 54797	cisplatin
T1949	dose 54805 54816	80.2 mg/m2)
T1951	activeingredient 54874 54884	aprepitant
T1953	activeingredient 55000 55018	aprepitant-treated
T1955	activeingredient 55248 55258	aprepitant
T1957	indication 55388 55418	Highly Emetogenic Chemotherapy
T1959	activeingredient 55457 55467	Aprepitant
T1961	activeingredient 55477 55487	Aprepitant
T1963	dose 55488 55494	125 mg
T1965	routeofadministration 55495 55501	orally
T1967	dose 55502 55507	80 mg
T1969	routeofadministration 55508 55514	orally
T1971	dose 55515 55520	80 mg
T1973	routeofadministration 55521 55527	orally
T1975	co-administereddrug 55534 55547	Dexamethasone
T1977	dose 55548 55553	12 mg
T1979	routeofadministration 55554 55560	orally
T1981	dose 55561 55565	8 mg
T1983	routeofadministration 55566 55572	orally
T1985	dose 55573 55577	8 mg
T1987	routeofadministration 55578 55584	orally
T1989	dose 55585 55589	8 mg
T1991	routeofadministration 55590 55596	orally
T1993	routeofadministration 55597 55598	5
T1995	co-administereddrug 55672 55685	Dexamethasone
T1997	dose 55686 55691	20 mg
T1999	routeofadministration 55692 55698	orally
T2001	dose 55699 55703	8 mg
T2003	routeofadministration 55704 55710	orally
T2005	dose 55723 55727	8 mg
T2007	routeofadministration 55728 55734	orally
T2009	frequency 55735 55746	twice daily
T2011	dose 55747 55751	8 mg
T2013	routeofadministration 55752 55758	orally
T2015	frequency 55759 55770	twice daily
T2017	co-administereddrug 55904 55915	Ondansetron
T2019	dose 55916 55921	32 mg
T2021	routeofadministration 55922 55926	I.V.
T2023	activeingredient 55962 55973	aprepitant.
T2025	co-administereddrug 56087 56098	ondansetron
T2027	activeingredient 56188 56198	aprepitant
T2029	activeingredient 56354 56364	aprepitant
T2031	routeofadministration 56565 56569	oral
T2033	activeingredient 56570 56580	aprepitant
T2035	activeingredient 57702 57712	Aprepitant
T2037	activeingredient 58924 58934	Aprepitant
T2039	activeingredient 60118 60128	aprepitant
T2041	activeingredient 60341 60351	aprepitant
T2043	activeingredient 60560 60570	aprepitant
T2045	activeingredient 60633 60643	aprepitant
T2047	indication 60788 60818	Highly Emetogenic Chemotherapy
T2049	activeingredient 61433 61443	aprepitant
T2051	indication 61902 61932	Highly Emetogenic Chemotherapy
T2053	tradename 62004 62009	EMEND
T2055	dose 62024 62030	150 mg
T2057	tradename 62055 62061	EMEND)
T2059	tradename 62062 62067	EMEND
T2061	dose 62082 62088	150 mg
T2063	tradename 62201 62206	EMEND
T2065	indication 62215 62248	prevention of nausea and vomiting
T2067	indication 62260 62264	HEC.
T2069	tradename 62332 62337	EMEND
T2071	dose 62352 62358	150 mg
T2073	routeofadministration 62394 62398	oral
T2075	activeingredient 62399 62409	aprepitant
T2077	indication 62472 62502	highly emetogenic chemotherapy
T2079	dose 62536 62545	70 mg/m2)
T2081	tradename 62654 62659	EMEND
T2083	activeingredient 62682 62692	aprepitant
T2085	indication 62988 62991	HEC
T2087	indication 63047 63077	Highly Emetogenic Chemotherapy
T2089	activeingredient 63115 63128	Fosaprepitant
T2091	activeingredient 63138 63151	Fosaprepitant
T2093	dose 63152 63158	150 mg
T2095	routeofadministration 63159 63172	intravenously
T2097	co-administereddrug 63189 63202	Dexamethasone
T2099	dose 63203 63208	12 mg
T2101	routeofadministration 63209 63215	orally
T2103	dose 63216 63220	8 mg
T2105	routeofadministration 63221 63227	orally
T2107	dose 63228 63232	8 mg
T2109	routeofadministration 63233 63239	orally
T2111	frequency 63240 63251	twice daily
T2113	dose 63252 63256	8 mg
T2115	routeofadministration 63257 63263	orally
T2117	frequency 63264 63275	twice daily
T2119	activeingredient 63335 63345	Aprepitant
T2121	activeingredient 63355 63365	Aprepitant
T2123	dose 63366 63372	125 mg
T2125	routeofadministration 63373 63379	orally
T2127	dose 63380 63385	80 mg
T2129	routeofadministration 63386 63392	orally
T2131	dose 63393 63398	80 mg
T2133	routeofadministration 63399 63405	orally
T2135	co-administereddrug 63412 63425	Dexamethasone
T2137	dose 63426 63431	12 mg
T2139	routeofadministration 63432 63438	orally
T2141	dose 63439 63443	8 mg
T2143	routeofadministration 63444 63450	orally
T2145	dose 63451 63455	8 mg
T2147	routeofadministration 63456 63462	orally
T2149	dose 63463 63467	8 mg
T2151	routeofadministration 63468 63474	orally
T2153	co-administereddrug 63666 63677	Ondansetron
T2155	dose 63678 63683	32 mg
T2157	routeofadministration 63684 63688	I.V.
T2159	tradename 63723 63728	EMEND
T2161	co-administereddrug 63858 63869	ondansetron
T2163	activeingredient 63926 63939	fosaprepitant
T2165	dose 63940 63946	150 mg
T2167	routeofadministration 64085 64089	oral
T2169	activeingredient 64090 64100	aprepitant
T2171	indication 64489 64519	Highly Emetogenic Chemotherapy
T2173	activeingredient 64582 64595	Fosaprepitant
T2175	activeingredient 64619 64629	Aprepitant
T2177	indication 65303 65343	Moderately Emetogenic Chemotherapy (MEC)
T2179	activeingredient 65451 65461	aprepitant
T2181	indication 65554 65588	moderately emetogenic chemotherapy
T2183	co-administereddrug 65611 65627	cyclophosphamide
T2185	dose 65628 65642	750-1500 mg/m2
T2187	co-administereddrug 65647 65663	cyclophosphamide
T2189	dose 65664 65678	500-1500 mg/m2
T2191	co-administereddrug 65683 65694	doxorubicin
T2193	dose 65696 65705	60 mg/m2)
T2195	co-administereddrug 65709 65719	epirubicin
T2197	dose 65721 65731	100 mg/m2)
T2199	co-administereddrug 65783 65799	cyclophosphamide
T2201	co-administereddrug 65802 65813	doxorubicin
T2203	co-administereddrug 65827 65843	cyclophosphamide
T2205	co-administereddrug 65846 65856	epirubicin
T2207	co-administereddrug 65859 65871	fluorouracil
T2209	activeingredient 65937 65947	aprepitant
T2211	activeingredient 66071 66089	aprepitant-treated
T2213	activeingredient 66310 66320	aprepitant
T2215	indication 66449 66483	Moderately Emetogenic Chemotherapy
T2217	activeingredient 66515 66525	Aprepitant
T2219	activeingredient 66535 66545	Aprepitant
T2221	dose 66546 66552	125 mg
T2223	routeofadministration 66553 66560	orally*
T2225	dose 66562 66567	80 mg
T2227	routeofadministration 66568 66574	orally
T2229	dose 66575 66580	80 mg
T2231	routeofadministration 66581 66587	orally
T2233	co-administereddrug 66588 66601	Dexamethasone
T2235	dose 66602 66607	12 mg
T2237	routeofadministration 66608 66614	orally
T2239	co-administereddrug 66626 66637	Ondansetron
T2241	dose 66638 66642	8 mg
T2243	routeofadministration 66643 66649	orally
T2245	co-administereddrug 66693 66706	Dexamethasone
T2247	dose 66707 66712	20 mg
T2249	routeofadministration 66713 66719	orally
T2251	co-administereddrug 66730 66741	Ondansetron
T2253	dose 66742 66746	8 mg
T2255	routeofadministration 66747 66753	orally
T2257	dose 66764 66768	8 mg
T2259	routeofadministration 66769 66775	orally
T2261	frequency 66776 66787	twice daily
T2263	dose 66788 66792	8 mg
T2265	routeofadministration 66793 66799	orally
T2267	frequency 66800 66811	twice daily
T2269	co-administereddrug 66923 66936	Dexamethasone
T2271	co-administereddrug 67008 67019	Ondansetron
T2273	co-administereddrug 67119 67130	ondansetron
T2275	routeofadministration 67165 67169	oral
T2277	activeingredient 67170 67180	aprepitant
T2279	activeingredient 68142 68152	Aprepitant
T2281	activeingredient 68746 68756	aprepitant
T2283	activeingredient 69102 69112	aprepitant
T2285	activeingredient 69647 69657	aprepitant
T2287	activeingredient 70093 70103	aprepitant
T2289	activeingredient 70285 70295	aprepitant
T2291	routeofadministration 70450 70452	IV
T2293	routeofadministration 70579 70581	IV
T2295	dose 70583 70598	&lt;1500 mg/m2)
T2297	routeofadministration 70614 70616	IV
T2299	dose 70618 70629	&gt;1 g/m2)
T2301	activeingredient 70687 70697	aprepitant
T2303	activeingredient 70916 70926	aprepitant
T2305	activeingredient 71151 71161	aprepitant
T2307	tradename 71408 71413	EMEND
T2309	activeingredient 71844 71854	Aprepitant
T2311	activeingredient 72212 72222	aprepitant
T2313	activeingredient 72405 72415	aprepitant
T2315	activeingredient 72673 72683	aprepitant
T2317	activeingredient 72965 72975	aprepitant
T2319	activeingredient 73230 73240	aprepitant
T2321	activeingredient 73413 73423	aprepitant
T2323	dose 73707 73713	115-mg
T2325	dose 73850 73856	150-mg
T2327	routeofadministration 74051 74062	intravenous
T2329	tradename 74307 74312	EMEND
T2331	tradename 74443 74448	EMEND
T2333	adversereaction 74472 74490	Allergic reactions
T2335	adversereaction 74544 74549	hives
T2337	adversereaction 74551 74555	rash
T2339	adversereaction 74557 74564	itching
T2341	adversereaction 74567 74591	redness of the face/skin
T2343	adversereaction 74606 74643	difficulty in breathing or swallowing
T2345	tradename 74722 74727	EMEND
T2347	adversereaction 74783 74801	allergic reaction.
T2349	adversereaction 74815 74836	severe skin reactions
T2351	adversereaction 74880 74902	infusion site reaction
T2353	adversereaction 74911 74919	erythema
T2355	adversereaction 74921 74926	edema
T2357	adversereaction 74928 74932	pain
T2359	adversereaction 74937 74953	thrombophlebitis
T2361	tradename 75051 75056	EMEND
T2363	co-administereddrug 75292 75300	warfarin
T2365	activeingredient 75454 75467	fosaprepitant
T2367	tradename 75517 75522	EMEND
T2369	co-administereddrug 75564 75588	hormonal contraceptives.
T2371	activeingredient 75737 75750	fosaprepitant
T2373	activeingredient 75754 75765	aprepitant.
T2375	company 75785 75814	Merck Sharp &amp; Dohme Corp.
T2377	company 75832 75847	MERCK &amp; CO.
T2379	company 75849 75853	INC.
T2381	company 75909 75928	DSM Pharmaceuticals
T2383	company 75930 75934	Inc.
T2385	u.s.patent 76019 76020	5
T2387	u.s.patent 76021 76024	512
T2389	u.s.patent 76025 76028	570
T2391	u.s.patent 76030 76031	5
T2393	u.s.patent 76032 76035	691
T2395	u.s.patent 76036 76039	336
T2397	company 76064 76093	Merck Sharp &amp; Dohme Corp.
T2399	company 76111 76126	Merck &amp; Co.
T2401	company 76128 76132	Inc.
